Follow @Jeevatrials for all future news and updates from Jeeva Informatics Solutions Inc on how we are accelerating the adoption of hybrid or fully Decentralized Clinical Trials.
We're currently in Phase 1A of COVID-19 vaccinations, which includes health care personnel. There is no vaccination beyond this group at this time. Info about future phases will be shared when it's available. Visit our vaccine webpage: https://t.co/zF3gmw6Bse
Have you listened to Patient Worthy's podcast? In this interview we talk to Harsha Rajasimha, the CEO and founder of @jeevainformatic about how clinical trials can change to better meet rare patient needs in the US, India, and across the world: https://t.co/u5oO6fKMGJ
Harsha Rajasimha founded Jeeva Informatics Solutions to solve problems with clinical trial recruitment. With help from the @masonsbdc, Harsha went through @ICAPVirginia, received an I-Corps grant from the NSF, & investment from @CITorg. https://t.co/i6V10rXG5V
#SmallBusinessWeek
Join us on July 10th at 9AM for a discussion panel on seed-stage investing. Panel members include Monique Adams of 757 Angels, James Ramey of VTC Fund, J.S. Gamble of Blu Venture Investors, and Tom Weithman of Virginia Founders Fund. https://t.co/p0f7y0PDa7
IndoUSrare Invitation to Inaugural Quarterly Webinar "The Rare Journey - Its What Unites Us" - by Nicole Boice Co-Founder RARE-X; Founder Global Genes - https://t.co/LLe7y8J1I4 @indousrare @nicoleboice@rvkartha@harsharajasimha@globalgenes#RARE-X
Decentralized Clinical Trials SaaS Platform for cell/gene therapy long-term follow up studies spanning 3-15 years with little or no travel - https://t.co/LD2JF6aWmZ
CIT GAP Funds Managing Director, @tomweithman, to Speak at Upcoming Virtual @TheInBIA Conference | Weithman will join other panel members to discuss innovative approaches to gain access to capital: https://t.co/NqbH6qS1G2
"About a quarter of the patients who review informed consents of clinical trials are unable to participate due to inability to travel to the site." -@Harsharajasimha#RDDS
We are not learning from past clinical trials and not improving our processes. We need to learn where people are dropping out of these trials and how these challenges can be addressed. -@Harsharajasimha#2020RDDS
Thank you for this incredible session on the use of #AI in gaining smart data and patient-driven research! @Harsharajasimha, @annastasiahmm, and Swagatam Mukhopadhyay #2020RDDS
How are #RareDisease patients being impacted by the #coronavirus pandemic? Patients & caregivers, please complete this 20-min online survey from the @NIH-funded @RareDiseasesNet. Find the survey & learn more at https://t.co/Xt7j22Tu6H @ncats_nih_gov#COVID19